Furthermore, it was reported that BCAFs with a high α-SMA expression are preferentially detected in more aggressive breast tumors, whereas less activated BCAFs showing a very low or no α-SMA expression are preferentially found in less aggressive BCs [62]. The gene discussed is ACTA1; the disease is breast neoplasm.